(2S,3R,4S,5R,6R)-2-((2R,3S,4R,5R)-6-(benzyloxy(3,4-dihydroxybenzyl)amino)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

ID: ALA3218193

Chembl Id: CHEMBL3218193

PubChem CID: 90665527

Max Phase: Preclinical

Molecular Formula: C26H35NO13

Molecular Weight: 569.56

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(N(Cc3ccc(O)c(O)c3)OCc3ccccc3)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C26H35NO13/c28-10-17-19(32)20(33)23(36)26(39-17)40-24-18(11-29)38-25(22(35)21(24)34)27(37-12-13-4-2-1-3-5-13)9-14-6-7-15(30)16(31)8-14/h1-8,17-26,28-36H,9-12H2/t17-,18-,19+,20+,21-,22-,23-,24-,25?,26+/m1/s1

Standard InChI Key:  OADLFTHGFHOCPB-AZSYEFFYSA-N

Associated Targets(Human)

HRAS Tchem Transforming protein p21/H-Ras-1 (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 569.56Molecular Weight (Monoisotopic): 569.2108AlogP: -2.34#Rotatable Bonds: 10
Polar Surface Area: 222.23Molecular Species: NEUTRALHBA: 14HBD: 9
#RO5 Violations: 3HBA (Lipinski): 14HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.25CX Basic pKa: CX LogP: -1.54CX LogD: -1.55
Aromatic Rings: 2Heavy Atoms: 40QED Weighted: 0.11Np Likeness Score: 1.11

References

1. Sacco E, Abraham SJ, Palmioli A, Damore G, Bargna A, Mazzoleni E, Gaponenko V, Vanoni M, Peri F.  (2011)  Binding properties and biological characterization of new sugar-derived Ras ligands,  (5): [10.1039/C0MD00264J]

Source